Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00914069 · ClinicalTrials.gov registry record · NA
Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter
A NA study, sponsored by C. R. Bard.
- Terminated
- Registry status
- NA
- Development phase
- 175
- Enrollment target
NCT00914069 is a NA study that was terminated before completion, run by C. R. Bard. The registered enrollment target is 175 participants.
The verdict
NCT00914069, a NA study, was terminated before completion, sponsored by C. R. Bard.
- TERMINATED
- Registry status
- NA
- Development phase
- 175 participants
- Enrollment target
Study Summary
The study will test a hypothesis that the RIVS system will have a higher rate of successful first PIV placement compared to conventional catheter without a significant increase in complications and time of procedure.
Interventions
- DEVICE RIVS vascular access
- DEVICE Conventional vascular access
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2009-06 |
| Est. Completion | 2013-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00914069
The ClinicalTrials.gov registry entry for NCT00914069 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which RIVS vascular access is the first listed.
NCT00914069 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00914069 about?
NCT00914069 is a clinical study titled "Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter". The study will test a hypothesis that the RIVS system will have a higher rate of successful first PIV placement compared to conventional catheter without a significant increase in complications and time of procedure.
What is the current status of trial NCT00914069?
This trial is currently terminated. It is a NA study. The enrollment target is 175 participants. The study started on 2009-06. Estimated completion is 2013-08.
What interventions are being tested in trial NCT00914069?
The interventions under investigation include: RIVS vascular access (DEVICE), Conventional vascular access (DEVICE).
Who is sponsoring clinical trial NCT00914069?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.